Albertsons Companies (ACI) Q4 2024 earnings summary

Executive summary

• Q4 identical sales grew 2.3% year-over-year, with digital sales up 24% and loyalty members increasing 15% to over 45M.

• Adjusted EBITDA for Q4 was $855M, with adjusted EPS at $0.46, reflecting strong digital and pharmacy performance.

• Leadership transition underway: CEO Vivek Sankaran retiring May 1, 2025, with Susan Morris named as successor.

• Strategic priorities include digital engagement, loyalty expansion, pharmacy growth, technology modernization, and productivity improvements.

• Fiscal 2024 identical sales grew 2.0%, digital sales up 24%, and adjusted EBITDA reached $4,005M.

Financial highlights

• Q4 net sales and other revenue were $18.8B, up from $18.3B, driven by pharmacy and digital sales growth.

• Q4 gross margin was 27.4%, down from 28.0% year-over-year, mainly due to pharmacy and digital mix.

• Adjusted EBITDA for Q4 was $855M (down from $916M last year); adjusted EPS was $0.46 (down from $0.54).

• Capital expenditures in Q4 were $485M, focused on store modernization and digital platforms.

• Selling and administrative expenses held steady at 25.7% of net sales in Q4.

Outlook and guidance

• Fiscal 2025 guidance: 1.5%-2.5% identical sales growth, adjusted EBITDA of $3.8-$3.9B, and adjusted EPS of $2.03-$2.16, including ~$65M EBITDA and ~$0.03 EPS from a 53rd week.

• Capital expenditures expected at $1.7-$1.9B for 2025.

• Effective tax rate projected at 23.5%-24.5%.

• Long-term targets include 2%+ identical sales and higher EBITDA growth in 2026 and beyond.